Insider Transactions Reported by 18 Insiders of Skye Bioscience, Inc.

Symbol
SKYE on Nasdaq
Location
San Diego, CA

Insiders trading volume in the past year

Skye Bioscience, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
5AM Partners VII, LLC 10%+ Owner $34.7M -$801K -2.26% 21 Aug 2025
Andrew J. Schwab Director, 10%+ Owner $34.7M -$801K -2.26% 21 Aug 2025
Versant Ventures III, LLC 10%+ Owner $9.39M 18 Aug 2023
Emerald Health Sciences Inc. 10%+ Owner $3.17M 10 Nov 2022
PUNIT DHILLON Chief Executive Officer, Director $1.69M 24 Feb 2025
Paul A. Grayson Director $1.3M 24 Feb 2025
KAITLYN ARSENAULT Chief Financial Officer $836K 24 Feb 2025
Tuan Tu Diep Chief Development Officer $410K 24 Feb 2025
Christopher Twitty Chief Scientific Officer $147K 23 Apr 2025
MARGARET DALESANDRO Director 29 Feb 2024
PRAVEEN TYLE Director 29 Feb 2024
Karen L. Smith Director 24 Feb 2025
Keith Wayne Ward Director 29 Feb 2024
JAMES L. HEPPELL Director 14 Sep 2021
Annalisa Jenkins Director 24 Feb 2025
Sukhwinder Singh Rai Director 05 Jan 2023
Deborah H. Charych Director 24 Feb 2025
Puneet S. Arora Chief Medical Officer 24 Feb 2025

Recent Insider Transactions by Companies or Individuals for Skye Bioscience, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.